What is the duration of steroid-induced mania?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration and Management of Steroid-Induced Mania

Steroid-induced mania can persist for several months after steroid discontinuation and requires active treatment with mood stabilizers or antipsychotics to control symptoms. 1

Typical Duration and Presentation

  • Steroid-induced neuropsychiatric symptoms, including mania, typically appear within a few days after starting glucocorticoid therapy but can sometimes develop after months of treatment, even with low doses 2
  • While most cases resolve shortly after steroid discontinuation, some patients experience persistent manic symptoms that can last for several months despite stopping the medication 1, 3
  • Symptoms can include insomnia, psychiatric adverse effects such as mania and psychosis, particularly in predisposed individuals 4

Risk Factors

  • Pre-existing mental illness increases susceptibility to steroid-induced mania 5
  • Family history of mood disorders, particularly bipolar disorder, may represent a risk factor 5
  • Acquired brain injury may predispose patients to steroid-induced neuropsychiatric effects 5
  • High-dose steroid therapy carries greater risk, but even small doses (as low as 10 mg prednisolone daily) can trigger mania with prolonged use 2

Management Approach

Immediate Interventions

  • Discontinue or reduce the steroid dose when possible, in consultation with the prescribing physician 6, 2
  • For severe symptoms, hospitalization may be necessary to ensure patient safety 1
  • If steroids cannot be discontinued due to medical necessity, consider:
    • Switching to a different steroid preparation with potentially fewer neuropsychiatric effects 4
    • Using the lowest effective dose possible 2

Pharmacological Management

  • For persistent manic symptoms, mood stabilizers such as sodium valproate are recommended as first-line treatment 1
  • Antipsychotics (quetiapine, olanzapine) are effective for controlling acute manic symptoms 1, 6
  • Some cases may be resistant to a single agent and require combination therapy 3
  • Treatment should be continued until complete resolution of symptoms, which may take weeks to months 1
  • Once the patient is stable, medications can be slowly tapered and discontinued, with careful monitoring for recurrence 1

Monitoring and Follow-up

  • Regular psychiatric assessment is essential during the recovery period 1
  • Monitor for recurrence of symptoms, especially during medication taper 4
  • Follow-up for at least one year is recommended to ensure sustained remission 1

Special Considerations

  • Steroid-induced mania can occur through various routes of administration, including systemic, inhaled, and even topical preparations like eye drops 6
  • In cases where continued steroid treatment is medically necessary, prophylactic mood stabilizers may be considered for patients with risk factors 5
  • For treatment-resistant cases, electroconvulsive therapy may be considered, though response can be variable 3

Prognosis

  • Most patients with steroid-induced mania have good long-term outcomes after appropriate treatment 1
  • Complete resolution of symptoms is expected, though the timeline varies significantly between patients 1, 3
  • Patients who have experienced steroid-induced mania are at higher risk for recurrence with future steroid exposure 5

References

Research

Persistent mania following cessation of corticosteroids.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2018

Research

Mania after long-term treatment with daily 10 mg prednisolone.

PCN reports : psychiatry and clinical neurosciences, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.